We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First-in-Human Trial Evaluating Ebola Treatment Begins

News   May 24, 2018 | Original story from NIH

 
First-in-Human Trial Evaluating Ebola Treatment Begins

A healthy volunteer receives an intravenous infusion of mAb114 -- an experimental treatment for Ebola virus disease -- in a Phase 1 clinical trial held at the NIH Clinical Center in Bethesda, Maryland. Credit: NIAID

 
 
 

RELATED ARTICLES

Poo Transplant Shows Promise in Prelim Study for Ulcerative Colitis

News

Anaerobically prepared fecal microbiota transplantation improved remission rates in people with moderately active ulcerative colitis at 8 weeks. Further research is needed to assess longer-term efficacy and safety.

READ MORE

Concern Over Fake ISO 9001 Accreditation of Chinese Companies

News

A study concludes that fake ISO 9001 quality certificates are very widespread across Chinese companies and that the certification processes of the auditing companies lack credibility.

READ MORE

$11M Study to Jumpstart Radiation Exposure Drug Development

News

The U.S. Department of Defense has turned to the University of Nebraska to jumpstart the development of drug therapies to protect military service members from the effects of radiation exposure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE